ResMed: Solid Execution, Pricey Valuation
Analyzing ResMed Inc.'s Q1 2025 results, stock performance, and sentiment to determine if further upside or profit taking is ...
Insider Activity Spotlight: Michael J Farrell Acquires In ResMed Stock Options
What Happened: In a Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday, Farrell, Chief Executive Officer at ResMed, acquired stock options for 33,036 shares of RMD. These ...